Maximus, Inc. MMS reported better-than-expected second-quarter fiscal 2025 results. Quarterly adjusted earnings of $2.01 per share beat the Zacks Consensus Estimate by 46.7% and increased 28% year over year. Revenues of $1.36 billion topped the consensus mark by 5.8% and rose 1% from the year-ago quarter. Maximus, Inc. Price, Consensus and EPS Surprise Maximus, Inc. price-consensus-eps-surprise-chart | Maximus, Inc. Quote Segmental Revenues of Maximus The U.S. Federal Services segment’s revenues of $777.9 million rose 11% from the year-ago reported number and beat our estimate of $687.2 million. The Outside the U.S. segment’s revenues of $141.5 million decreased 12% year over year and outpaced our anticipated $123.1 million. The U.S. Services segment’s revenues of $442.4 million decreased 9% year over year and missed our estimate of $497.2 million. MMS’ Sales and Pipeline Year-to-date signed contract awards, as of March 31, 2025, totaled $2.92 billion. Contracts pending (awarded but unsigned) amounted to $451 million. The sales pipeline, as of March 31, was $41.2 billion. This included $1.97 billion in pending proposals, $3 billion in proposals in preparation, and $36.3 billion in opportunities tracking. The book-to-bill ratio was 0.8X on a trailing 12-month basis. MMS’ Operating Performance Operating income of $153 million increased 20% year over year. This compares with our expected adjusted operating income of $138.6 million, down 16.2% year over year. The adjusted operating income margin of 11.2% increased 170 basis points year over year. Maximus’ Balance Sheet and Cash Flow Maximus ended the quarter with a cash and cash equivalent balance of $108 million compared with $73 million reported at the end of the prior quarter. The company generated $42.7 million in cash from operations. Capital expenditures were $17.2 million, and free cash flow amounted to $25.5 million. MMS Updated Fiscal 2025 Guidance Maximus has raised earnings and revenue guidance for fiscal year 2025. Total revenues are now expected between $5.25 billion and $5.4 billion compared with the previous expectation of $5.2 billion and $5.35 billion. The midpoint ($5.325 billion) of the raised guided range is above the Zacks Consensus Estimate of $5.31 billion. Adjusted earnings are anticipated in the range of $6.30-$6.60 per share compared with the previous expectations of $5.90-$6.20 per share. The updated guided range is higher than the current Zacks Consensus Estimate of $6.08. The company expects an adjusted EBITDA margin of approximately 11.7% compared with 11.2% expected earlier. Story Continues Free cash flow expectation stayed unchanged between $355 million and $385 million. The company forecasts interest expenses of approximately $78 million compared with the prior anticipation of $75 million. The effective income tax rate is anticipated to be within 28-29%. On a full-year basis, the weighted average shares outstanding are forecasted to be approximately 58 million shares. Currently, Maximus carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here. Earnings Snapshot S&P Global Inc. SPGI reported impressive first-quarter 2025 results. SPGI’s adjusted EPS of $4.37 surpassed the Zacks Consensus Estimate by 3.6% and gained 9% year over year. Revenues of $3.8 billion beat the consensus estimate by 2% and grew 8.3% year over year. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.) Verisk VRSK has reported impressive first-quarter fiscal 2025 results. VRSK’s adjusted earnings were $1.73 per share, surpassing the Zacks Consensus Estimate by 3.6% and increasing 6.1% from the year-ago quarter. Total revenues of $753 million beat the consensus estimate marginally and increased 7% on a year-over-year basis. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Verisk Analytics, Inc. (VRSK):Free Stock Analysis Report Maximus, Inc. (MMS):Free Stock Analysis Report S&P Global Inc. (SPGI):Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research View Comments
Maximus' Q2 Earnings & Revenues Beat Estimates, Increase Y/Y
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...